JP2011502968A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011502968A5 JP2011502968A5 JP2010531519A JP2010531519A JP2011502968A5 JP 2011502968 A5 JP2011502968 A5 JP 2011502968A5 JP 2010531519 A JP2010531519 A JP 2010531519A JP 2010531519 A JP2010531519 A JP 2010531519A JP 2011502968 A5 JP2011502968 A5 JP 2011502968A5
- Authority
- JP
- Japan
- Prior art keywords
- preparation according
- preparation
- luteinizing hormone
- concentration
- hlh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07119832.9 | 2007-11-01 | ||
| EP07119832 | 2007-11-01 | ||
| US448107P | 2007-11-28 | 2007-11-28 | |
| US61/004,481 | 2007-11-28 | ||
| PCT/EP2008/064679 WO2009056569A1 (en) | 2007-11-01 | 2008-10-29 | Lh liquid formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011502968A JP2011502968A (ja) | 2011-01-27 |
| JP2011502968A5 true JP2011502968A5 (enExample) | 2011-12-22 |
| JP5551601B2 JP5551601B2 (ja) | 2014-07-16 |
Family
ID=39167502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010531519A Active JP5551601B2 (ja) | 2007-11-01 | 2008-10-29 | Ｌｈ液体調製物 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8664369B2 (enExample) |
| EP (1) | EP2219607B1 (enExample) |
| JP (1) | JP5551601B2 (enExample) |
| KR (1) | KR101513181B1 (enExample) |
| CN (1) | CN101842083B (enExample) |
| AU (1) | AU2008320844B2 (enExample) |
| BR (1) | BRPI0818324B8 (enExample) |
| CA (1) | CA2700662C (enExample) |
| CY (1) | CY1113121T1 (enExample) |
| DK (1) | DK2219607T3 (enExample) |
| EA (1) | EA019432B1 (enExample) |
| EC (1) | ECSP10010224A (enExample) |
| ES (1) | ES2393233T3 (enExample) |
| HR (1) | HRP20120660T1 (enExample) |
| IL (1) | IL205105A (enExample) |
| MX (1) | MX2010004639A (enExample) |
| MY (1) | MY153976A (enExample) |
| NZ (1) | NZ583991A (enExample) |
| PL (1) | PL2219607T3 (enExample) |
| PT (1) | PT2219607E (enExample) |
| RS (1) | RS52566B (enExample) |
| SI (1) | SI2219607T1 (enExample) |
| UA (1) | UA101484C2 (enExample) |
| WO (1) | WO2009056569A1 (enExample) |
| ZA (1) | ZA201001907B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2613152T3 (es) | 2008-01-09 | 2017-05-22 | Sanofi-Aventis Deutschland Gmbh | Nuevos derivados de insulina con perfil tiempo/acción extremadamente retardado |
| CA3016451A1 (en) | 2008-10-17 | 2010-04-22 | Sanofi-Aventis Deutschland Gmbh | Combination of an insulin and a glp-1 agonist |
| JP2011001273A (ja) * | 2009-06-16 | 2011-01-06 | Eci Inc | ｅＭＩＰを有効成分とする水溶性製剤 |
| SG10201403840VA (en) * | 2009-07-06 | 2014-10-30 | Sanofi Aventis Deutschland | Aqueous insulin preparations containing methionine |
| DK2498802T3 (en) | 2009-11-13 | 2015-04-13 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a GLP-1 agonist, insulin and a methionine |
| PL3345593T3 (pl) | 2009-11-13 | 2024-04-08 | Sanofi-Aventis Deutschland Gmbh | Kompozycja farmaceutyczna zawierająca desPro36-eksendynę-4(1-39)-Lys6-NH2 i metioninę |
| WO2011099036A2 (en) * | 2010-02-12 | 2011-08-18 | Intas Biopharmaceuticals Limited | Liquid formulation of follicle stimulating hormone |
| PT2611458T (pt) | 2010-08-30 | 2016-12-16 | Sanofi Aventis Deutschland | Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| CN102293756A (zh) * | 2011-08-24 | 2011-12-28 | 蚌埠丰原涂山制药有限公司 | 一种尿促性素冻干粉针剂及其制备方法 |
| DK2750699T3 (en) | 2011-08-29 | 2015-10-26 | Sanofi Aventis Deutschland | A pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| AU2013368990B2 (en) * | 2012-12-26 | 2017-05-18 | Wockhardt Limited | Pharmaceutical composition |
| TWI641381B (zh) | 2013-02-04 | 2018-11-21 | 法商賽諾菲公司 | 胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物 |
| US20160024181A1 (en) | 2013-03-13 | 2016-01-28 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| KR20160104724A (ko) | 2014-01-09 | 2016-09-05 | 사노피 | 인슐린 유사체 및/또는 인슐린 유도체의 안정화된 약제학적 제형 |
| MX2016008977A (es) | 2014-01-09 | 2016-10-04 | Sanofi Sa | Formulaciones farmaceuticas de insulina aspart estabilizadas. |
| WO2015104311A1 (en) | 2014-01-09 | 2015-07-16 | Sanofi | Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives |
| ES2949095T3 (es) | 2014-12-12 | 2023-09-25 | Sanofi Aventis Deutschland | Formulación de relación fija de insulina glargina/lixisenatida |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
| GB201603280D0 (en) * | 2016-02-24 | 2016-04-13 | Ferring Bv | Stable liquid gonadotropin formulation |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE64738B1 (en) * | 1990-03-20 | 1995-09-06 | Akzo Nv | Stabilized gonadotropin containing preparations |
| IT1250075B (it) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
| US5681302A (en) * | 1994-06-14 | 1997-10-28 | Minnesota Mining And Manufacturing Company | Elastic sheet-like composite |
| JP4165718B2 (ja) * | 1995-03-21 | 2008-10-15 | ラボラトワール セローノ ソシエテ アノニム | ｈＣＧ液体製剤 |
| IL122732A0 (en) * | 1997-01-15 | 1998-08-16 | Akzo Nobel Nv | Liquid gonadotropin-containing formulation its preparation and a device containing same |
| WO2000004913A1 (en) * | 1998-07-23 | 2000-02-03 | Eli Lilly And Company | Fsh and fsh variant formulations, products and methods |
| PT1599222E (pt) * | 2003-01-08 | 2009-06-12 | Novartis Vaccines & Diagnostic | Composições aquosas estabilizadas que contêm um inibidor da via do factor tecidular (tfpi) ou uma variante do inibidor da via do factor tecidular |
| US7387998B2 (en) | 2003-03-28 | 2008-06-17 | New York University | STQ peptides |
| RS57872B1 (sr) * | 2003-04-02 | 2018-12-31 | Ares Trading Sa | Tečne farmaceutske formulacije fsh i lh zajedno sa nejonskim surfaktantom |
-
2008
- 2008-10-29 CA CA2700662A patent/CA2700662C/en not_active Expired - Fee Related
- 2008-10-29 US US12/681,688 patent/US8664369B2/en active Active
- 2008-10-29 CN CN2008801145250A patent/CN101842083B/zh active Active
- 2008-10-29 MX MX2010004639A patent/MX2010004639A/es active IP Right Grant
- 2008-10-29 UA UAA201006712A patent/UA101484C2/ru unknown
- 2008-10-29 ES ES08844750T patent/ES2393233T3/es active Active
- 2008-10-29 KR KR1020107012131A patent/KR101513181B1/ko active Active
- 2008-10-29 NZ NZ583991A patent/NZ583991A/en unknown
- 2008-10-29 RS RS20120484A patent/RS52566B/sr unknown
- 2008-10-29 PL PL08844750T patent/PL2219607T3/pl unknown
- 2008-10-29 HR HRP20120660AT patent/HRP20120660T1/hr unknown
- 2008-10-29 EP EP08844750A patent/EP2219607B1/en active Active
- 2008-10-29 BR BRPI0818324A patent/BRPI0818324B8/pt active IP Right Grant
- 2008-10-29 WO PCT/EP2008/064679 patent/WO2009056569A1/en not_active Ceased
- 2008-10-29 DK DK08844750.3T patent/DK2219607T3/da active
- 2008-10-29 AU AU2008320844A patent/AU2008320844B2/en active Active
- 2008-10-29 JP JP2010531519A patent/JP5551601B2/ja active Active
- 2008-10-29 SI SI200830735T patent/SI2219607T1/sl unknown
- 2008-10-29 PT PT08844750T patent/PT2219607E/pt unknown
- 2008-10-29 MY MYPI2010001950A patent/MY153976A/en unknown
- 2008-10-29 EA EA201070549A patent/EA019432B1/ru not_active IP Right Cessation
-
2010
- 2010-03-17 ZA ZA2010/01907A patent/ZA201001907B/en unknown
- 2010-04-15 IL IL205105A patent/IL205105A/en active IP Right Grant
- 2010-05-31 EC EC2010010224A patent/ECSP10010224A/es unknown
-
2012
- 2012-09-13 CY CY20121100836T patent/CY1113121T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011502968A5 (enExample) | ||
| HRP20120660T1 (hr) | Tekuće formulacije lh | |
| HRP20200998T1 (hr) | Postupak i sastav za liječenje okularne hipertenzije i glaukoma | |
| FI4374878T3 (fi) | Karbetosiinia käsittävä farmaseuttinen koostumus | |
| JP2013543492A5 (enExample) | ||
| KR101940341B1 (ko) | 약학 조성물 | |
| HRP20110801T1 (hr) | Tekući oblik fsh | |
| JP2015527402A5 (enExample) | ||
| TWI635874B (zh) | 艾妥鈣塞(etelcalcetide)(amg 416)之穩定液體調配物 | |
| JP2012519695A5 (enExample) | ||
| HRP20191994T1 (hr) | Formulacije ketorolaka spremne za uporabu | |
| US20250195439A1 (en) | Method for treating local lesion disease | |
| JP2015524444A5 (enExample) | ||
| HRP20110444T1 (hr) | Formulacije paratiroidnih hormona i njihove uporabe | |
| CN102821782B (zh) | 促卵泡激素的液体配制品 | |
| BRPI0920973B1 (pt) | composição aquosa contendo hormônio estimulanete de folículos | |
| JP2015535237A5 (enExample) | ||
| JP5149308B2 (ja) | 局所的鼻腔投与のためのオロパタジンの製剤 | |
| CA2797658A1 (en) | Casein peptide for use in the treatment of uterine infections | |
| CA2571183A1 (en) | Composition comprising lactic acid and lactoferrin | |
| HRP20211696T1 (hr) | Postupak izrade fluoriranih olefina | |
| AR067047A1 (es) | Formulaciones acuosas de acetaminofen para inyeccion. | |
| RU2011134414A (ru) | Комбинация фульвовой кислоты для лечения различных состояний и болезней | |
| CN101972257B (zh) | 一种含有莫西沙星的药物组合物 | |
| AR062894A1 (es) | Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (ths) |